Policy, capital, and patents are remaking the semiconductor industry. The winners will own the manufacturing IP that transfers into domestic fabs.
The Semiconductor IP Arms Race: $52B in Subsidies, $20B Acquisitions, and the Patents That Will Decide Who Wins
$52 billion in CHIPS Act subsidies. $20 billion for Groq. $1.6 billion for SambaNova. The semiconductor IP war just went nuclear.
January 2026 has been the most consequential month for semiconductor strategy in a decade. Trump imposed 25% tariffs on AI chips. NVIDIA acquired Groq. Intel finalized SambaNova. Cerebras announced a $22B IPO.
Behind the headlines, a patent land grab is happening that will determine who controls AI infrastructure for the next decade.
Semiconductor patent filings have exploded since the CHIPS Act passed in 2022. The numbers tell the story:
From 2020 to 2025, semiconductor manufacturing patents grew 340% in the United States alone. AI accelerator patents grew even faster, at 520%.
Why? Because $52 billion in federal subsidies comes with strings attached. To qualify for CHIPS Act funding, companies must demonstrate domestic manufacturing capability and a credible IP risk plan.
That means patents.
Intel, TSMC, Samsung, and GlobalFoundries are all racing to build US fabs. But fabs are just buildings. The patents that cover advanced packaging, extreme ultraviolet lithography, and chip interconnects determine whether those fabs can actually compete.
The semiconductor patent landscape is dominated by a handful of giants, but the composition is shifting.
TSMC leads with manufacturing process patents covering 3nm and below. Their EUV lithography patents alone number over 2,400 families.
Samsung is close behind, with strength in memory (HBM) and advanced packaging. Their 3D stacking patents are critical for AI chips that need massive memory bandwidth.
Intel has pivoted hard. Their patent focus shifted from x86 architecture to AI accelerators and packaging technology. The SambaNova acquisition adds 400+ patents in AI inference optimization.
NVIDIA is the wildcard. Historically light on manufacturing IP, they are buying what they cannot build. The Groq acquisition adds deterministic scheduling patents that make inference 10x more predictable.
Then there are the challengers:
Cerebras has 180+ patents on wafer-scale manufacturing that no one else can replicate. Their thermal management IP alone is worth the $22B valuation if wafer-scale becomes the standard.
AMD is often overlooked, but their chiplet architecture patents are licensing gold. Every competitor building modular chips needs to navigate AMD’s portfolio.
Three technology clusters are driving the patent race:
Advanced Packaging (34% of recent filings)
Chiplets, 3D stacking, and hybrid bonding. This is where the action is. Intel’s Foveros, TSMC’s CoWoS, and Samsung’s X-Cube are all patent-protected. Companies building AI systems need to license or design around.
AI Accelerators (28% of recent filings)
Custom silicon for inference and training. NVIDIA dominates GPUs, but Google (TPU), Amazon (Trainium), and Microsoft (Maia) are all building and patenting alternatives. The Groq acquisition signals NVIDIA is worried about inference-specific architectures.
Manufacturing Processes (22% of recent filings)
EUV lithography, gate-all-around transistors, and backside power delivery. ASML holds the keys to EUV, but the process patents that use EUV are spread across TSMC, Samsung, and Intel.
The CHIPS Act is reshaping where patents get filed.
US patent filings for semiconductors grew 89% from 2022 to 2025. Taiwan filings grew only 12%. The money is pulling innovation onshore.
But China is not standing still. Despite export controls, Chinese semiconductor patent filings grew 156% in the same period. Companies like SMIC and Huawei are patenting around restrictions, building portfolios for the day controls ease.
The risk for US companies: Chinese patents filed today could block US market entry into China tomorrow. The reverse is also true.
Founders should pay attention to the rebuild of the semiconductor supply chain. Every layer, from wafers to packaging to testing, needs new suppliers. Companies with manufacturing IP that works in US fabs can command premium valuations, especially in packaging, testing, and yield optimization.
Investors should track patent filings as a leading indicator. Companies adding manufacturing IP, not just design IP, are positioning for the CHIPS Act era. The Cerebras IPO will test whether the market values architectural diversity over NVIDIA’s software moat.
Acquirers are already pricing this shift. NVIDIA’s Groq deal and Intel’s SambaNova deal both point to the same conclusion: inference, packaging, and process IP can change acquisition math quickly.
Inside counsel and strategy teams have a harder map to maintain. Domestic manufacturing pressure can expose companies to patent positions they previously avoided through offshore supply chains. Supply-chain mapping and patent mapping now belong in the same conversation.
The semiconductor industry is being remade by policy, capital, and patents. The winners will be companies that:
Three patterns matter:
First, the CHIPS Act is a patent accelerator. $52B in subsidies means every dollar of R&D will be patented and defended.
Second, acquisitions signal the strategy. When NVIDIA pays $20B for inference IP, they are telling you what matters.
Third, geography is destiny. Patents filed in the US for US manufacturing will be worth more than equivalent patents filed elsewhere.
The semiconductor IP arms race is not coming. It is here.
What is your position?
Need to understand what this means for your portfolio? ipCapital Group helps leadership teams turn patent landscapes into practical decisions about filing strategy, competitive diligence, M&A readiness, and monetization.
Start a conversation with ipCapital Group or download the IP Strategy Playbook.
Work with ipCapital Group
From invention to monetization, our team has guided 2,000+ engagements across the full IP lifecycle. Start with a free 30-minute discovery call.
Written by
Seth Cronin